Septic bursitis: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Treatment==" to "==Management==") |
ClaireLewis (talk | contribs) |
||
| Line 25: | Line 25: | ||
**Suspected joint involvement | **Suspected joint involvement | ||
**Immunocompromise | **Immunocompromise | ||
**Failure to resopnd to course of PO | **Failure to resopnd to course of PO antibiotics | ||
==See Also== | ==See Also== | ||
Revision as of 01:06, 14 July 2016
Background
- Most common sites are prepatellar bursa and olecranon bursa
Clinical Features
- Acute pain, tenderness, warmth, and erythema of affected bursa
- None of which is seen in aseptic bursitis
- Fever (<50%)
Differential Diagnosis
Diagnosis
- Bursal fluid aspiration
- Both diagnostic and therapeutic
Management
Antibiotics
Cover Staphylococcus aureus (80-90%) and Streptococcus
Outpatient Options
- Clindamycin 300 mg PO three times daily x 14 days OR
- TMP/SMX 2 DS tabs PO two times daily x 14 days OR
- Dicloxacillin 500mg PO q6hr x10 days
Treatment followup with primary physician is important since the regimen may need extension to 3 weeks.
Inpatient Options
- Vancomycin 25-30 mg/kg IV loading then 15-20 mg/kg IV OR
- Clindamycin 600 mg (10/mg/kg) IV three times daily
- Linezolid 600 mg IV BID (10mg/kg Q8hrs for pediatrics)
Disposition
- Consider admission for:
- Extensive purulent bursitis
- Extensive surrounding cellulitis
- Suspected joint involvement
- Immunocompromise
- Failure to resopnd to course of PO antibiotics